RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
Public ClinicalTrials.gov record NCT04616924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study of RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease in Adults With Nodular Bronchiectasis (CleaR-MAC Trial)
Study identification
- NCT ID
- NCT04616924
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- RedHill Biopharma Limited
- Industry
- Enrollment
- 12 participants
Conditions and interventions
Interventions
- RHB-204 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2020
- Primary completion
- Aug 27, 2023
- Completion
- Aug 27, 2023
- Last update posted
- Mar 17, 2025
2020 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Facility | Glendale | California | 91205 | — |
| Medical Facility | Palm Springs | California | 92262 | — |
| Medical Facility | Farmington | Connecticut | 06030-1225 | — |
| Medical Facility | Washington D.C. | District of Columbia | 20007 | — |
| Medical Facility | Clearwater | Florida | 33765 | — |
| Medical Facility | Gainesville | Florida | 32610 | — |
| Medical Facility | Margate | Florida | 33063 | — |
| Medical Facility 1 | Orlando | Florida | 32803 | — |
| Medical Facility 2 | Orlando | Florida | 32803 | — |
| Medical Facility | Sebring | Florida | 33870 | — |
| Medical Facility | Vero Beach | Florida | 32960 | — |
| Medical Facility | Atlanta | Georgia | 30342 | — |
| Medical Facility | Valdosta | Georgia | 31605 | — |
| Medical Facility | Kansas City | Kansas | 66160 | — |
| Medical Facility | New Orleans | Louisiana | 70112 | — |
| Medical Facility | Boston | Massachusetts | 02215 | — |
| Medical Facility | Rochester | Minnesota | 55902 | — |
| Medical Facility | St Louis | Missouri | 63110 | — |
| Medical Facility | Newark | New Jersey | 07103 | — |
| Medical Facility | New York | New York | 10029 | — |
| Medical Facility | Winston-Salem | North Carolina | 27103 | — |
| Medical Facility | Portland | Oregon | 97239 | — |
| Medical Facility | Charleston | South Carolina | 29425 | — |
| Medical Facility | Tyler | Texas | 75708 | — |
| Medical Facility | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04616924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04616924 live on ClinicalTrials.gov.